June 3rd, 2007 - 01:16 GMT New Drug in the Treatment of Abdominal Obesity with Associated Risk Factors Sanofi-Aventis today announced the launch of Acomplia (rimonabant), their new scientific drug for the treatment of abdominally obese patients with car Read more
